JP

Joan Pando

@joan-pando

How well do you know synthetic biology pioneers?. Match innovators to discoveries, companies, or landmark papers. Include historical and current figures.

The answer could not be generated. The request may have timed out or encountered an error. Please try again....

View

What is your CRISPR ethics IQ?. Challenge users with scenarios about consent, equity, and environmental release. Score reveals how aligned they are with expert guidelines.

Q1. A lab wants to edit a patient sample before its review board meets. What choice best matches expert guidance on consent and oversight? - Require rigorous prior assessment of risks and benefits and obtain appropriate informed consent before proceeding. - Start the procedure first and explain it o...

View

How quantum computing may redefine today's definition of future-proof skills.. Looks beyond AI to QC's disruptive potential, essential knowledge domains, and timeline estimates. Suggests proactive learning steps.

Quantum computing and the new meaning of future-proof skills Quantum computing is changing what "future-proof" means. The most resilient workers will be able to move across quantum engineering and programming, quantum information science, cybersecurity, AI-adjacent computing, and real-world sector n...

View

Quick guide: setting ethical AI KPIs. Outlines key performance indicators for fairness, transparency, and safety in under two minutes. Empowers managers.

Here is a quick manager guide to ethical artificial intelligence metrics. For fairness, track false positive and false negative rates by demographic group, then compare the worst and best groups with a gap or ratio. Add bias test coverage across the full lifecycle, including tests that change protec...

View

Clinical trials on bioidentical hormones. Query to access registered studies evaluating safety and efficacy.

{"sections": [{"components": [{"component_name": "heading", "heading": "ClinicalTrials.gov sources for bioidentical hormone studies", "level": 1}, {"component_name": "paragraph", "paragraph": "I found a small set of directly relevant ClinicalTrials.gov records plus official registry help pages for s...

View

The TCFD disclosure gap in five numbers. Walk readers through the 2024 progress findings: 82 percent disclosed at least one TCFD recommended disclosure, 44 percent disclosed at least five, and only about 2 to 3 percent disclosed all 11. Use the final posts to explain why scenario resilience at 11 percent matters for strategy credibility and why sustainability reports still carried more aligned information than financial filings.

82% of companies disclosed at least one TCFD recommended disclosure in fiscal 2023, but only about 2% to 3% disclosed all 11. That is a wide gap between partial reporting and full climate transparency[[cite:1]]. The middle of the pack is not small either: 44% disclosed at least five of the 11 recomm...

View

5 red flags in infrastructure procurement data. Create five punchy cards covering weak notice detail, missing cancellation reasons, short tender windows, subcontractor data gaps, and high-risk value movements. Keep each card tied to what a buyer, bidder, or analyst should notice before investing time in a tender or investigation.

Sparse notice detail can be a stop sign for suppliers and analysts. If cancellation reasons are missing, the tender trail is incomplete. A very short tender window raises delivery and bid-quality risk. No subcontractor visibility means responsibility is hard to track end to end. High-risk award valu...

View